These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 78718)
21. A proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen-induced nasal congestion. Barchuk WT; Salapatek AM; Ge T; D'Angelo P; Liu X J Allergy Clin Immunol; 2013 Oct; 132(4):838-46.e1-6. PubMed ID: 23791513 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed. Dockhorn RJ; Williams BO; Sanders RL Ann Allergy Asthma Immunol; 1996 Feb; 76(2):204-8. PubMed ID: 8595542 [TBL] [Abstract][Full Text] [Related]
23. Canine model of nasal congestion and allergic rhinitis. Tiniakov RL; Tiniakova OP; McLeod RL; Hey JA; Yeates DB J Appl Physiol (1985); 2003 May; 94(5):1821-8. PubMed ID: 12547842 [TBL] [Abstract][Full Text] [Related]
24. Nasal decongestant activity of pseudoephedrine. Roth RP; Cantekin EI; Bluestone CD; Welch RM; Cho YW Ann Otol Rhinol Laryngol; 1977; 86(2 pt. 1):235-42. PubMed ID: 322570 [TBL] [Abstract][Full Text] [Related]
25. Actifed, a combination of pseudoephedrine with an antihistamine in the symptomatic treatment of resistant allergic rhinitis. FEINBERG SM; FEINBERG AR; FISHERMAN EW J Indiana State Med Assoc; 1959 Dec; 52():2137-8. PubMed ID: 13849773 [No Abstract] [Full Text] [Related]
26. Changes in nasal resistance and nasal geometry using pressure and acoustic rhinometry in a feline model of nasal congestion. McLeod RL; Mingo GG; Herczku C; Corboz MR; Ramos SI; DeGennaro-Culver F; Pedersen O; Hey JA Am J Rhinol; 1999; 13(5):375-83. PubMed ID: 10582116 [TBL] [Abstract][Full Text] [Related]
27. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit. Berkowitz RB; Woodworth GG; Lutz C; Weiler K; Weiler J; Moss M; Meeves S Ann Allergy Asthma Immunol; 2002 Jul; 89(1):38-45. PubMed ID: 12141718 [TBL] [Abstract][Full Text] [Related]
29. Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Baroody FM; Foster KA; Markaryan A; deTineo M; Naclerio RM Ann Allergy Asthma Immunol; 2008 Mar; 100(3):194-9. PubMed ID: 18426137 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of clemastine-pseudoephedrine-acetaminophen versus pseudoephedrine-acetaminophen in the treatment of seasonal allergic rhinitis in a 1-day, placebo-controlled park study. Meltzer EO; Casale TB; Gold MS; O'Connor R; Reitberg D; del Rio E; Weiler JM; Weiler K Ann Allergy Asthma Immunol; 2003 Jan; 90(1):79-86. PubMed ID: 12546342 [TBL] [Abstract][Full Text] [Related]
31. Loratadine/pseudoephedrine for nasal symptoms in seasonal allergic rhinitis: a double-blind, placebo-controlled study. McFadden EA; Gungor A; Ng B; Mamikoglu B; Moinuddin R; Corey J Ear Nose Throat J; 2000 Apr; 79(4):254, 257-8, 260 passim. PubMed ID: 10786387 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion. Stübner UP; Toth J; Marks B; Berger UE; Burtin B; Horak F Arzneimittelforschung; 2001 Nov; 51(11):904-10. PubMed ID: 11765592 [TBL] [Abstract][Full Text] [Related]
33. Methoxyphenamine inhibits basal and histamine-induced nasal congestion in anaesthetized rats. Lau WA; King RG; Boura AL Br J Pharmacol; 1990 Oct; 101(2):394-8. PubMed ID: 1701679 [TBL] [Abstract][Full Text] [Related]
34. Combined histamine H1 and H3 receptor blockade produces nasal decongestion in an experimental model of nasal congestion. McLeod RL; Mingo GG; Herczku C; DeGennaro-Culver F; Kreutner W; Egan RW; Hey JA Am J Rhinol; 1999; 13(5):391-9. PubMed ID: 10582118 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the effects of astemizole/pseudoephedrine and triprolidine/pseudoephedrine on CNS activity and psychomotor function. Stanley N; Alford CA; Rombaut NE; Hindmarch I Int Clin Psychopharmacol; 1996 Mar; 11(1):31-6. PubMed ID: 8732311 [TBL] [Abstract][Full Text] [Related]
36. Nasal airway response to infused phenylephrine in normals and in patients with allergic and non-allergic rhinitis. Brooks CD; Spenner GC; Karl KJ; Heissler CT; Metzler CM Rhinology; 1988 Mar; 26(1):51-8. PubMed ID: 3368711 [TBL] [Abstract][Full Text] [Related]
37. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine. Baroody FM; Ford S; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM Am J Respir Crit Care Med; 1994 Jun; 149(6):1457-65. PubMed ID: 7516250 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of optical rhinometry for nasal provocation testing in allergic and nonallergic subjects. Luong A; Cheung EJ; Citardi MJ; Batra PS Otolaryngol Head Neck Surg; 2010 Aug; 143(2):284-9. PubMed ID: 20647136 [TBL] [Abstract][Full Text] [Related]
39. Visual hallucinations in children receiving decongestants. Sankey RJ; Nunn AJ; Sills JA Br Med J (Clin Res Ed); 1984 May; 288(6427):1369. PubMed ID: 6201227 [No Abstract] [Full Text] [Related]
40. The effects of oral pseudoephedrine on nasal patency in the common cold: a double-blind single-dose placebo-controlled trial. Taverner D; Danz C; Economos D Clin Otolaryngol Allied Sci; 1999 Feb; 24(1):47-51. PubMed ID: 10196648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]